Sutthichai Nakphook

5PUBLICATIONS
17CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safetyEpidemiology not elsewhere classifiedPacific Peoples theory of change models for healthInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 26, 2026
Safety and Immunogenicity of an Additional Dose of Thailand Government Pharmaceutical Organization (GPO) Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Administered After Primary Vaccination with HXP-GPOVac or BNT162b2: An Open-Label Phase II Extension Trial in Thai Adults.

|Jun 25, 2026
Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults.

|May 30, 2026
Risk of Hospitalization Related to Influenza A(H3N2) Virus Subclade K, Thailand, June-December 2025.

|Aug 14, 2025
Perceptions of influenza and SARS-CoV-2 vaccination among health care personnel in Thailand, 2024.

Kriengkrai Prasert, Prabda Praphasiri, Darunee Ditsungnoen

|Jun 09, 2021
Antibody responses induced by trivalent inactivated influenza vaccine among pregnant and non-pregnant women in Thailand: A matched cohort study.

Sutthichai Nakphook, Jayanton Patumanond, Manash Shrestha

Pageof 1

Frequent Collaborators

3 joint publications

Kriengkrai Prasert

2 joint publications

William W Davis

2 joint publications

Bruce L Innis

2 joint publications

Christina S Polyak